Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Providence Therapeutics Announces Partnership with University Health Network (UHN) for mRNA Therapeutic Discovery and Development
Providence Therapeutics, a biopharmaceutical company developing messenger RNA (mRNA) vaccines and therapeutics, today announced its […]
TriLink BioTechnologies® Announces Manufacturing Capabilities Expansion as mRNA Manufacturing Facility Nears Completion
TriLink BioTechnologies, a Maravai LifeSciences company and global provider of life science reagents and services, […]
BioCina Has Been Awarded Grants to Develop mRNA Vaccines
BioCina, a leading contract development and manufacturing organization (CDMO) is pleased to announce that it […]
Strand Therapeutics Appoints Colleen Wilson as Chief People Officer
Strand Therapeutics, the programmable mRNA company developing curative therapies for cancer and other diseases, today […]
Samyang Holdings Enters Partnership with LG Chem for the Development of Innovative Cancer Therapeutics
Samyang Holdings and LG Chem have announced their recent execution of strategic partnership agreement on […]
Nutcracker Therapeutics Demonstrates Immunotherapeutic Potency of Lead mRNA Candidate
Nutcracker Therapeutics, a biotechnology company dedicated to developing transformative RNA therapies through its proprietary technology […]
Strand Therapeutics Presents Preclinical Data on Programmable mRNA Therapy STX-001 at AACR 2023
Strand Therapeutics, the programmable mRNA company developing curative therapies for cancer and other diseases, announced […]
ReCode Therapeutics Announces First Participants Dosed in a Healthy Volunteer Clinical Trial for the Treatment of Primary Ciliary Dyskinesia
ReCode Therapeutics, a private, clinical-stage genetic medicines company using superior delivery to power the next […]
Porton Advanced Collaborates with DanausGT to Accelerate the Development of Gene and Cell Therapy
Porton Advanced and DanausGT Biotechnology have announced a strategic collaboration in gene and cell therapy […]
- Charles River and INADcure Announce Gene Therapy Manufacturing Collaboration Read more
- Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease Read more
- Genmab Showcases Data From Comprehensive Epcoritamab Development Program in Patients Across B-Cell Lymphomas Read more
- Quell Therapeutics Signs Agreement with AstraZeneca to Develop and Commercialize Engineered Treg Cell Therapies for Autoimmune Diseases Read more
- Astellas and Kate Therapeutics Announce Exclusive License Agreement for KT430 Read more